BofA reiterates Buy on AstraZeneca stock, cites adjuvant trial outlook

BofA reiterates Buy on AstraZeneca stock, cites adjuvant trial outlook

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.